HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laxminarayan Bhat Selected Research

Sleep Initiation and Maintenance Disorders (Insomnia)

11/2017Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laxminarayan Bhat Research Topics

Disease

4Schizophrenia (Dementia Praecox)
10/2018 - 01/2017
3Psychotic Disorders (Schizoaffective Disorder)
10/2018 - 01/2017
3Pulmonary Arterial Hypertension
05/2018 - 09/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2024
1Body Weight (Weight, Body)
11/2017
1Orthostatic Hypotension (Postural Hypotension)
11/2017
1Sleep Initiation and Maintenance Disorders (Insomnia)
11/2017
1Hypertrophy
09/2017
1Cognitive Dysfunction
01/2017

Drug/Important Bio-Agent (IBA)

8RP5063IBA
02/2024 - 01/2017
5Serotonin (5 Hydroxytryptamine)IBA
02/2024 - 09/2017
4Dopamine (Intropin)FDA LinkGeneric
02/2024 - 09/2017
3Serotonin ReceptorsIBA
05/2018 - 09/2017
2MonocrotalineIBA
05/2018 - 09/2017
1CytokinesIBA
02/2024
1salicylhydroxamic acid (SHAM)IBA
02/2024
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
02/2024
1Sildenafil Citrate (Viagra)FDA Link
05/2018
1treprostinilFDA Link
05/2018
1Bosentan (Tracleer)FDA Link
05/2018
1LipidsIBA
11/2017
1Blood Glucose (Blood Sugar)IBA
11/2017
1ProlactinIBA
11/2017
1Antipsychotic Agents (Antipsychotics)IBA
01/2017

Therapy/Procedure

1Therapeutics
05/2018